Rajib Chandra Das

Rajib Chandra Das

Auto-generated profile, based on publicly available information

Rajib Chandra Das

Institute for Superconducting and Electronic Materials Faculty of Engineering and Information Sciences University of Wollongong Squires Way North Wollongong NSW 2500 Australia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2025 in Advanced Science
Verified
Journal Article
Open access
SMSusmita Mondal
Susmita Mondal
RDRajib Chandra Das
Rajib Chandra Das
YDYumeng Du
Yumeng Du
ZHZhenyuan Hou
Zhenyuan Hou
Konstantin KonstantinovKonstantin Konstantinov
Konstantin Konstantinov
Zhenxiang ChengZhenxiang Cheng
Zhenxiang Cheng
Flexocatalysis, a groundbreaking approach in mechanocatalysis, overcomes the material limitations imposed by the symmetry requirements of piezocatalysis, enabling a broader range of materials to generate free radicals through mechano‐catalytic reactions. This method not only offers an eco‐friendly pathway for green hydrogen production via water splitting but also facilitates the use of biocompatible materials in health diagnostics and treatments. In this study, the flexocatalytic activity of centrosymmetric SrTiO 3 (STO) nanopowders is demonstrated, achieving notable hydrogen evolution (1289.53 µmol g −1 h −1 in pure water) and efficient organic dye degradation (≈94%). The mechanism is driven by electric polarization generated under non‐uniform strain, which is strongly enhanced with particle size reduction, effectively linking flexoelectricity to superior electrochemical performance. The findings highlight the potential of flexocatalysis to revolutionize hydrogen production and broaden the range of materials for catalytic applications, paving the way for innovative energy‐harvesting technologies.

1 April 2023 in Journal of Ginseng Research
Verified
Journal Article
Open access
RDRajib Chandra Das
Rajib Chandra Das
ZRZubair Ahmed Ratan
Zubair Ahmed Ratan
MRMd Mustafizur Rahman
Md Mustafizur Rahman
NRNusrat Jahan Runa
Nusrat Jahan Runa
SMSusmita Mondal
Susmita Mondal
Jae Youl ChoJae Youl Cho
Jae Youl Cho
Due to the Covid-19 pandemic more than 6 million people have died, and it has bought unprecedented challenges to our lives. The recent outbreak of monkeypox virus (MPXV) has brought out new tensions among the scientific community. Currently, there is no specific treatment protocol for MPXV. Several antivirals, vaccinia immune globulin (VIG) and smallpox vaccines have been used to treat MPXV. Ginseng, one of the more famous among traditional medicines, has been used for infectious disease for thousands of years. It has shown promising antiviral effects. Ginseng could be used as a potential adaptogenic agent to help prevent infection by MPXV along with other drugs and vaccines. In this mini review, we explore the possible use of ginseng in MPXV prevention based on its antiviral activity.

1 September 2023 in Journal of Ginseng Research
Verified
Journal Article
Open access
ZRZUBAIR AHMED RATAN
ZUBAIR AHMED RATAN
RDRajib Chandra Das
Rajib Chandra Das
Jae Youl ChoJae Youl Cho
Jae Youl Cho